{"id":"https://openalex.org/W3036328220","doi":"https://doi.org/10.1161/circulationaha.120.046251","title":"The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y 12 Inhibitor in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis","display_name":"The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y 12 Inhibitor in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis","alternate_titles":[],"publication_year":2020,"publication_date":"2020-06-19","ids":{"openalex":"https://openalex.org/W3036328220","doi":"https://doi.org/10.1161/circulationaha.120.046251","mag":"3036328220","pmid":"https://pubmed.ncbi.nlm.nih.gov/32551860"},"language":"en","primary_location":{"id":"doi:10.1161/circulationaha.120.046251","doi":"https://doi.org/10.1161/circulationaha.120.046251","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.120.046251","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.046251","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3036328220"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.046251","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081943616","display_name":"Michelle L. O\u2019Donoghue","orcid":"https://orcid.org/0000-0002-8663-0067","observed_orcids":["https://orcid.org/0000-0002-8663-0067"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210159766","display_name":"Thrombolysis in Myocardial Infarction Study Group","ror":"https://ror.org/05vp7ha71","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michelle L. O\u2019Donoghue","raw_affiliation_strings":["TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I4210159766"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085897222","display_name":"Sabina A. Murphy","orcid":"https://orcid.org/0000-0002-8231-3611","observed_orcids":["https://orcid.org/0000-0002-8231-3611"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210159766","display_name":"Thrombolysis in Myocardial Infarction Study Group","ror":"https://ror.org/05vp7ha71","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sabina A. Murphy","raw_affiliation_strings":["TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, Boston, MA","Sabina A. Murphy TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I4210159766"]},{"raw_affiliation_string":"Sabina A. Murphy TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I4210159766"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030057930","display_name":"Marc Steven Sabatine","orcid":"https://orcid.org/0000-0002-0691-3359","observed_orcids":["https://orcid.org/0000-0002-0691-3359"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210159766","display_name":"Thrombolysis in Myocardial Infarction Study Group","ror":"https://ror.org/05vp7ha71","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc S. Sabatine","raw_affiliation_strings":["TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, Boston, MA","Marc S. Sabatine https://orcid.org/0000-0002-0691-3359 TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-0691-3359","affiliations":[{"raw_affiliation_string":"TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I4210159766"]},{"raw_affiliation_string":"Marc S. Sabatine https://orcid.org/0000-0002-0691-3359 TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I4210159766"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.4139,"has_fulltext":true,"cited_by_count":158,"citation_normalized_percentile":{"value":0.97146984,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"142","issue":"6","first_page":"538","last_page":"545"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aspirin-discontinuation","display_name":"aspirin discontinuation","score":0.9919999837875366},{"id":"https://openalex.org/keywords/p2y12-inhibitors","display_name":"P2Y12 inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/dual-antiplatelet-therapy","display_name":"dual antiplatelet therapy","score":0.9599999785423279},{"id":"https://openalex.org/keywords/percutaneous-coronary-intervention","display_name":"percutaneous coronary intervention","score":0.9340000152587891},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.796999990940094},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.7749999761581421},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":0.9020000100135803},{"id":"https://openalex.org/keywords/prasugrel","display_name":"prasugrel","score":0.9629999995231628},{"id":"https://openalex.org/keywords/ticagrelor","display_name":"ticagrelor","score":1.0},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.8349999785423279},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.9129999876022339},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.6959999799728394},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.5059999823570251},{"id":"https://openalex.org/keywords/bleeding-risk-stratification","display_name":"bleeding risk stratification","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.936646580696106},{"id":"https://openalex.org/C2780739214","wikidata":"https://www.wikidata.org/wiki/Q6723023","display_name":"Mace","level":4,"score":0.8376153707504272},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.7917501926422119},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.7435026168823242},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.7219874858856201},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.7206000685691833},{"id":"https://openalex.org/C2780890252","wikidata":"https://www.wikidata.org/wiki/Q420542","display_name":"Ticagrelor","level":4,"score":0.7077192068099976},{"id":"https://openalex.org/C2777028646","wikidata":"https://www.wikidata.org/wiki/Q416232","display_name":"Prasugrel","level":4,"score":0.6862456202507019},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6696832180023193},{"id":"https://openalex.org/C45393284","wikidata":"https://www.wikidata.org/wiki/Q191012","display_name":"Conventional PCI","level":3,"score":0.6523672938346863},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6185525059700012},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.5828335285186768},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.46211034059524536},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4459705948829651},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3842751979827881},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068799","descriptor_name":"Prasugrel Hydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077144","descriptor_name":"Clopidogrel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077486","descriptor_name":"Ticagrelor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000080903","descriptor_name":"Dual Anti-Platelet Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011183","descriptor_name":"Postoperative Complications","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D028761","descriptor_name":"Withholding Treatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D058921","descriptor_name":"Purinergic P2Y Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D062645","descriptor_name":"Percutaneous Coronary Intervention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1161/circulationaha.120.046251","doi":"https://doi.org/10.1161/circulationaha.120.046251","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.120.046251","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.046251","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:32551860","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32551860","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1161/circulationaha.120.046251","doi":"https://doi.org/10.1161/circulationaha.120.046251","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.120.046251","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.046251","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320315949","display_name":"IFM Therapeutics","ror":"https://ror.org/00hq8t831"},{"id":"https://openalex.org/F4320319139","display_name":"Zora Biosciences","ror":"https://ror.org/00t2dw182"},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320331660","display_name":"Esperion Therapeutics","ror":"https://ror.org/019f2k932"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3036328220.pdf","grobid_xml":"https://content.openalex.org/works/W3036328220.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W311320695","https://openalex.org/W1553345686","https://openalex.org/W1886686547","https://openalex.org/W1985059672","https://openalex.org/W2022506351","https://openalex.org/W2024352468","https://openalex.org/W2087150869","https://openalex.org/W2098923148","https://openalex.org/W2104595603","https://openalex.org/W2119605658","https://openalex.org/W2120643945","https://openalex.org/W2122779695","https://openalex.org/W2125173296","https://openalex.org/W2140501627","https://openalex.org/W2159370853","https://openalex.org/W2167918232","https://openalex.org/W2169387542","https://openalex.org/W2361921955","https://openalex.org/W2529708946","https://openalex.org/W2556417520","https://openalex.org/W2888458270","https://openalex.org/W2921724943","https://openalex.org/W2949986921","https://openalex.org/W2953479758","https://openalex.org/W2955952534","https://openalex.org/W2970684805","https://openalex.org/W2975423547","https://openalex.org/W2976166882","https://openalex.org/W2979056151","https://openalex.org/W2982456693","https://openalex.org/W3147141922"],"related_works":["https://openalex.org/W7163669736","https://openalex.org/W7223570890","https://openalex.org/W7203712198","https://openalex.org/W3108395385","https://openalex.org/W7164155184","https://openalex.org/W4387575494","https://openalex.org/W7171366329","https://openalex.org/W4308374963","https://openalex.org/W6966907033","https://openalex.org/W3111646834"],"abstract_inverted_index":{"Background:":[0],"Dual":[1],"antiplatelet":[2,87,199],"therapy":[3,180,200],"with":[4,25,38,77,84,126,135,197,211,305,338],"aspirin":[5,26,47,70,179,265,304],"and":[6,105,131,155,173,283],"a":[7,146,169],"P2Y":[8,51,79,147,307],"12":[9,52,80,97,148,308],"inhibitor":[10,53,81,149,309],"has":[11],"been":[12],"shown":[13],"to":[14,72,98,182,268,287,318],"reduce":[15],"the":[16,109,140,189,216,289],"risk":[17,40,190,217,290,312,325],"of":[18,41,45,50,69,145,178,191,218,264,291,303,313,326,333],"major":[19,192],"adverse":[20],"cardiovascular":[21],"events":[22],"(MACE)":[23],"compared":[24,83,196],"alone":[27],"after":[28,75,101,185,266,321,331],"percutaneous":[29],"coronary":[30,35,128,137,259,340],"intervention":[31],"(PCI)":[32],"or":[33,157,238],"acute":[34,136,258,339],"syndrome":[36],"but":[37],"increased":[39,324],"bleeding.":[42],"The":[43,116],"safety":[44],"discontinuing":[46],"in":[48,112,152,159,215,261,336],"favor":[49],"monotherapy":[54,82,310],"remains":[55],"disputed.":[56],"Methods:":[57],"A":[58],"meta-analysis":[59],"was":[60,328],"conducted":[61],"from":[62,96],"randomized":[63],"trials":[64,90],"(2001\u20132020)":[65],"that":[66],"studied":[67],"discontinuation":[68,263,332],"1":[71,181,267,317],"3":[73,183,269,319],"months":[74,100,184,270,320],"PCI":[76,186,255],"continued":[78,306],"traditional":[85],"dual":[86,198],"therapy.":[88],"Five":[89],"were":[91,108,249],"included;":[92],"follow-up":[93],"duration":[94],"ranged":[95],"15":[99],"PCI.":[102,322],"Primary":[103],"bleeding":[104,171,193,272,314],"MACE":[106,219,292,327],"outcomes":[107],"prespecified":[110],"definitions":[111],"each":[113],"trial.":[114],"Results:":[115],"study":[117],"population":[118],"included":[119,150],"32":[120],"145":[121],"patients:":[122],"14":[123],"095":[124],"(43.8%)":[125],"stable":[127],"artery":[129],"disease":[130],"18":[132],"046":[133],"(56.1%)":[134],"syndrome.":[138,341],"In":[139,164],"experimental":[141],"arm,":[142],"background":[143],"use":[144],"clopidogrel":[151],"2649":[153],"(16.5%)":[154],"prasugrel":[156],"ticagrelor":[158],"13":[160],"408":[161],"(83.5%)":[162],"patients.":[163],"total,":[165],"820":[166],"patients":[167,252,337],"experienced":[168,175],"primary":[170],"outcome":[172],"937":[174],"MACE.":[176],"Discontinuation":[177,302],"significantly":[187],"reduced":[188,271],"by":[194,273],"40%":[195],"(1.97%":[201],"versus":[202,221,231,241,276,294],"3.13%;":[203],"hazard":[204],"ratio":[205],"[HR],":[206],"0.60":[207],"[95%":[208,225,235,245,280,298],"CI,":[209,226,236,246,281,299],"0.45\u20130.79]),":[210],"no":[212],"increase":[213,288],"observed":[214,330],"(2.73%":[220],"3.11%;":[222],"HR,":[223,233,243,278,296],"0.88":[224],"0.77\u20131.02]),":[227],"myocardial":[228],"infarction":[229],"(1.08%":[230],"1.27%;":[232],"0.85":[234,244,297],"0.69\u20131.06]),":[237],"death":[239],"(1.25%":[240],"1.47%;":[242],"0.70\u20131.03]).":[247,300],"Findings":[248],"consistent":[250],"among":[251],"who":[253],"underwent":[254],"for":[256],"an":[257],"syndrome,":[260],"whom":[262],"50%":[274],"(1.78%":[275],"3.58%;":[277],"0.50":[279],"0.41\u20130.61])":[282],"did":[284],"not":[285,329],"appear":[286],"(2.51%":[293],"2.98%;":[295],"Conclusions:":[301],"reduces":[311],"when":[315],"stopped":[316],"An":[323],"aspirin,":[334],"including":[335]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3036328220","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":22},{"year":2022,"cited_by_count":42},{"year":2021,"cited_by_count":35},{"year":2020,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-06-25T00:00:00"}
